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Professional Issue. 1 
Physiotherapy co-management of rheumatoid arthritis: 2 
Identification of red flags, significance to clinical practice 3 




Rheumatoid arthritis (RA) is a chronic, systemic, autoimmune disease.  Physiotherapy 8 
interventions for people with RA are predominantly targeted at ameliorating disability 9 
resulting from articular and peri-articular manifestations of the disease and providing advice 10 
and education to improve functional capacity and quality of life. To ensure safe and effective 11 
care, it is critical that physiotherapists are able to identify potentially serious articular and peri-12 
articular manifestations of RA, such as instability of the cervical spine. Additionally, as primary 13 
contact professionals, it is essential that physiotherapists are aware of the potentially serious 14 
extra-articular manifestations of RA.  This paper provides an overview of the practice-relevant 15 
manifestations associated with RA that might warrant further investigation by a medical 16 
practitioner (red flags), their relevance to physiotherapy practice, and recommended 17 
management pathways. 18 
 19 
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Rheumatoid arthritis (RA) is a systemic, autoimmune, inflammatory condition that affects 24 
multiple tissues and organs in the body, in particular the synovial joints and peri-articular 25 
tissues. It is the most common of the inflammatory joint diseases. RA is associated with 26 
significant pain, functional impairments and co-morbid health conditions (Kvien, 2004). In 27 
recognition of the substantial health, psychosocial and community impacts imposed by RA, this 28 
condition is recognised as a National Health Priority Area in Australia and current health 29 
policies address the need to optimise health service delivery (Department of Health (Western 30 
Australia), 2009; National Health Priority Action Council, 2006). The systemic and progressive 31 
nature of the condition and associated co-morbidities (Briggs et al., 2009) also contribute to 32 
premature mortality (Myasoedova et al., 2010), particularly in individuals who experience 33 
extra-articular (EA) manifestations associated with the disease. In order to ensure safe and 34 
effective patient care, clinicians working in primary care need to be able to readily identify 35 
manifestations which may contribute to morbidity and mortality and influence prognosis. 36 
 37 
Physiotherapy represents a critical component of the overall management for patients with 38 
RA, as substantiated by a strong evidence base, and reflected in clinical practice guidelines 39 
(Bell et al., 1998; Ottawa Panel, 2004a; Ottawa Panel, 2004b; Li et al., 2006a; Li et al., 2006b; 40 
Forestier et al., 2009; Royal Australian College of General Practitioners, 2009; Hurkmans et al., 41 
2011). Recent data suggest that the physiotherapy workforce needs professional development 42 
in the safe and effective delivery of clinical physiotherapy services. In particular, the ability of 43 
physiotherapists to identify the presence of red flags in patients with RA and implement 44 
appropriate on-referral was highlighted as an essential skill required for safe and effective care 45 
(Briggs et al., 2012; Fary et al., 2012). Red flags have been defined as the “clinical indicators of 46 
possible serious underlying conditions requiring further medical intervention” (Hunter New 47 
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England NSW Health, 2005, p.1) and “…manifestations that suggest that physician referral may 48 
be warranted” (Leerar et al., 2007, p. 42). The broader definitions of red flags may equally be 49 
attributed to those serious physical findings whose management is outside the scope of 50 
physiotherapy practice, e.g. visual disturbances related to scleritis. This professional issue 51 
article is written within the context of this broader definition. The aim of this paper is to 52 
provide an overview of articular, peri-articular and EA red flags associated with RA and 53 
highlight specifically what clinicians need to look and listen for in practice, and the practice 54 
implications.  55 
 56 
RHEUMATOID ARTHRITIS 57 
Although there is no cure for RA, early identification and initiation of appropriate therapies are 58 
important to arrest the progression of symptoms and improve longer-term outcomes (Finckh 59 
et al., 2006; van der Linden et al., 2010). Physiotherapists need to be able to: (i) recognise signs 60 
and symptoms (musculoskeletal and other body systems) that at pre-diagnosis suggest RA, and 61 
(ii) identify any serious disease or medical condition associated with RA that may lead to 62 
irreversible damage or premature death (Beattie et al., 2011).  63 
 64 
The following sections outline the articular, peri-articular and EA red flags associated with RA 65 
that are relevant to contemporary clinical practice. 66 
 67 
Articular and peri-articular red flags in RA 68 
Early recognition of the articular and peri-articular features of RA that may indicate disease-69 
specific severity and that require on-referral is important for the primary care clinician, as 70 




The typical disease course of RA involves chronic low-grade inflammation with periodic flares 73 
which may present as articular or peri-articular manifestations (Prete et al., 2011). 74 
Inflammatory mediators contribute to the progressive destruction of joint tissue in the 75 
absence of disease-modifying treatment (Tarner et al., 2005). Chronic synovial inflammation, 76 
bone erosion, and cartilage destruction within the joint may lead to joint instability in both 77 
appendicular and axial skeletons.  78 
 79 
Up to 86% of people with RA have involvement of the cervical spine (Mukerji and Todd, 2011), 80 
of whom 17-85% will progress to cervical spine instability (Wolfs et al., 2009). Furthermore, 81 
neurological deterioration is almost inevitable in patients with RA treated conservatively for 82 
cervical spine instability associated with myelopathy (Wolfs et al., 2009). The presence of 83 
cervical spine instability in RA also leads to a higher mortality rate (Paus et al., 2008; 84 
Wasserman et al., 2011).  Recognising the potential association between RA and joint 85 
instability and identifying risk is particularly critical in the cervical spine, where instability and 86 
subluxation (particularly in the upper cervical spine) can have catastrophic consequences 87 
leading to sudden, unexpected death (Neva et al., 2006; Paus et al., 2008; Wasserman et al., 88 
2011) or quadriplegia (Neva et al., 2006) due to compromise of the spinal cord and/or brain 89 
stem. Significantly, while a range of signs and symptoms are indicative of cervical spine 90 
involvement (Table 1), a large proportion of cervical instabilities are asymptomatic (Collins et 91 
al., 1991; Neva et al., 2006) highlighting the need for clinical vigilance in patients with RA. 92 
Moreover, the severity of cervical instability has been associated with the severity of RA 93 
activity in peripheral joints (Hirano et al., 2012) and a long duration of disease (Neva et al., 94 
2006), further highlighting the need for clinical vigilance in this context. A recent survey of 95 
Australian physiotherapists indicated that only 64.4% of respondents would test for cranio-96 
cervical instability when treating the upper cervical spine of patients with RA (Osmotherly and 97 
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Rivett, 2011). A clinical case on upper cervical spine instability in RA is published in this issue of 98 
Manual Therapy (Slater et al. 2013).  99 
 100 
Instability also occurs in peripheral joints and may require splinting or surgical stabilisation to 101 
reduce symptoms and improve function.  102 
 103 
Commonly occurring peri-articular conditions associated with RA include: tenosynovitis (often 104 
the first sign of inflammatory joint disease (Hmamouchi et al., 2011)) and tendon rupture; 105 
boutonnière deformity, swan neck deformity and carpal tunnel syndrome in the hand, and 106 
hallux valgus, medial longitudinal arch flattening and claw toe in the foot (Table 1). Notably, 107 
early evidence of hand deformities is a reliable indicator of more severe disease (Johnsson and 108 
Eberhardt, 2009), highlighting the importance of early recognition and appropriate 109 
intervention or on-referral.  110 
 111 
Practice points  112 
Assessing and monitoring disease severity is an important clinical skill. Tools to assist clinicians 113 
have recently been identified and could readily form part of best evidence practice including 114 
communication with the RA team or GP (Anderson et al., 2012).  115 
Risk/benefit analysis: recommend screening for signs and symptoms of RA prior to 116 
implementing management, especially in the upper cervical spine: on-refer if in doubt. 117 
Increased vigilance in using manual techniques in the cervical spine if suspicion of instability 118 
especially C1/C2. 119 
 120 
INSERT TABLE 1 HERE 121 
Extra-articular red flags in RA 122 
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As RA is a systemic, autoimmune disease, multiple organs and systems may also be affected. 123 
Understanding the implications of systemic disease involvement means that physiotherapy 124 
management can be better informed and contraindications to management are identified at 125 
an early stage, ensuring safe and effective patient care (Table 2).  126 
 127 
Extra-articular features are largely influenced by inflammatory mediators associated with the 128 
disease process (Hochberg et al., 2008) and have a significant influence on prognosis (Turesson 129 
et al., 2002; Prete et al., 2011). For example, in a recent review on the epidemiology of EA 130 
features in patients with RA, based on studies with RA cohorts of greater than 100 patients, 131 
Prete et al. 2011 reported an overall incidence of 28% (19.8% non-severe form and 8.3% 132 
severe forms). The authors reported a greater incidence in northern European countries and 133 
among smokers, highlighting the role of environmental and genetic factors in their aetiology. 134 
Severe EA features may occur in individuals with recently diagnosed RA (Turesson et al., 1999).  135 
 136 
Most EA features are an expression of rheumatoid vasculitis, occurring as a consequence of 137 
chronic inflammation, causing organ-specific manifestations, usually in the cutaneous (Figure 138 
1) and neurological systems (Genta et al., 2006), but may also occur in other systems (Table 2), 139 
such as the visual system (Figure 2). Drug-induced conditions associated with RA are also 140 
significant, for example glucocorticoid-induced osteoporosis and diabetes mellitus, and the 141 
increased susceptibility to cancer and infections as a consequence of immunosuppressive 142 
agents. Table 2 provides an overview of practice-relevant EA features and co-morbidities, 143 
adapted from Young and Koduri (2007) and Prete et al. (2011). 144 
 145 
While a large volume of studies have been undertaken to characterise the epidemiology of EA 146 
manifestations of RA, comparability between studies is limited due to substantial sampling 147 
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differences, the absence of a standard classification system for these manifestations (Turesson 148 
and Jacobsson, 2004; Young and Koduri, 2007; Prete et al., 2011) and the complexity in 149 
distinguishing these manifestations from co-morbid conditions associated with drug therapies 150 
and disease duration (Young and Koduri, 2007; Prete et al., 2011).  151 
 152 
INSERT TABLE 2 HERE 153 
INSERT FIGURE 1 AND FIGURE 2 HERE 154 
 155 
Practice points 156 
A thorough patient history and physical examination are critical in patients with RA (see 157 
Castrejón et al., 2012).  158 
Identification of EA features requires a thorough clinical assessment, including screening for 159 
other systemic signs (e.g.; dyspnoea, skin lesions, itchy eyes), in conjunction with screening for 160 
articular and peri-articular features (e.g. Figures 1-2).  161 
Cardiac, neurological and pulmonary manifestations have the potential to cause disability and 162 
may require modification of physiotherapy management. Reduced cardiac, pulmonary and 163 
neuromuscular performance may lead to fatigue, dyspnoea and reduced capacity to engage in 164 
aerobic and strengthening exercise and perform functional tasks.  165 
EA features require a broad consideration of management and may indicate the need for on-166 
referral.  Referral communications should highlight key aspects of a patient’s medical history 167 
that suggest RA (see Jack et al. 2012). 168 
 169 
Assessing and monitoring disease activity 170 
The use of screening tools in clinical practice may alert the clinician to the presence of an 171 
inflammatory joint condition and assist in identifying red flags and recognising the implications 172 
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for physiotherapy management. Current recommendations for clinically-appropriate tools to 173 
measure RA disease activity are available (Anderson et al., 2012). A self-administered early 174 
inflammatory arthritis detection tool has also been developed for use in primary care (Bell et 175 
al., 2010). Although the psychometric and scoring properties of the instrument are yet to be 176 
established, use of the 11-item instrument in physiotherapy practice may help alert the 177 
clinician to possible RA or other inflammatory joint disease. Further, use of the gait, arms, legs 178 
and spine (GALS) locomotor screening examination for RA (recently tested for use among 179 
physiotherapists) has high specificity, suggesting utility as a physical screening test in primary 180 
care settings (Beattie et al., 2011). 181 
 182 
While this review is focussed on red flags, psychological co-morbidities (such as depression and 183 
anxiety) commonly associated with pain and impaired function as a consequence of chronic 184 
and progressive diseases such as RA (McKnight-Eily et al., 2009) should be screened for and  185 
on –referral is recommended when appropriate. 186 
 187 
SUMMARY 188 
RA is a chronic, progressive and serious systemic condition, potentially causing death. Timely 189 
identification of potentially serious articular, peri-articular and EA manifestations of RA is 190 
imperative to ensure safe and effective patient care and enhances the role of the 191 
physiotherapist as part of an interdisciplinary health professional team. Timely on-referral of 192 
patients to a general practitioner, rheumatologist or orthopaedic surgeon can minimise delays 193 
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Table 1 Articular and peri-articular manifestations associated with rheumatoid arthritis, representing potential red flags 
Articular and peri-articular 
manifestations 
Listening for: reports of Looking for: examination and findings 
Cervical spine instability Pain at the back of the head and/or neck. 
Sensory and motor changes in the upper limbs. 
Vertebro-basilar artery insufficiency symptoms. 
Lips and tongue sensory disturbance.  
Symptoms of spinal cord compromise, including 
possible lower limb symptoms such as gait 
disturbances. 
Thorough subjective and physical examination 
including comprehensive neurological examination; 
view computed tomography/magnetic resonance 
images to ascertain cervical cord compromise, 
especially C1/C2; Babinski/Hoffman sign, clonus, 
reflexes, sensation. 
(see Slater et al. 2013) 
Tenosynovitis Swollen, painful tendons. 
Pain on resisted movement/load. 
Crepitus on movement; warmth; evidence of 
swelling. 
Tendon rupture and/or joint 
dislocations of the hand/wrist or 
foot/ankle joints 
Loss of function; deformity 
 
Rupture: loss of tendon function, joint instability 
and tendon discontinuity. Discordance between 
active and passive joint movement. 
Dislocation: lack of synovial joint congruity in active 
and passive movement. 
Boutonnière deformity Mechanical dysfunction related to fine motor tasks 
using the digits and gross motor tasks using the hand 
and wrist. 
Combination of flexion of proximal IP joint and 
hyperextension of distal IP joint.  
Swan neck deformity Mechanical dysfunction related to fine motor tasks 
using the digits and gross motor tasks using the hand 
and wrist. 
Limitation of active flexion of the proximal IP joint. 
IP joint instability. 
Combination of flexion at MCP joint, 
hyperextension of the proximal IP joint and flexion 
of the distal IP joint. 
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Carpal tunnel syndrome Pain and/or sensory disturbance in the hand in the 
median nerve distribution; wasting or weakness with 
gripping; dropping things; symptoms worse at night; 
shaking the hand helps. 
Sensory and motor examination of relevant 
peripheral median nerve distribution (negate 
differential spinal root compression that may 
mimic carpal tunnel involvement). 
Positive Phalen’s and Tinel’s tests. 
Screen for diabetes, thyroidism, B12 deficiency. 
Weakness or wasting in abductor pollicis brevis. 
Hallux valgus, medial longitudinal 
arch flattening and claw toe 
Pain in the foot. 
Reports of increased disability with gait and weight-
bearing. 
Postural and alignment changes in the foot, 
including: medial deviation of the first metatarsal 
and lateral deviation of the hallux.  
Pattern of dorsiflexion at MTP joint combined with 
plantar flexion at PIP and DIP joints for claw toes. 
Synovitis-driven rotator cuff and/or 
glenohumeral symptoms 
Shoulder girdle pain (e.g.; impingement or lateral 
shoulder pain) not mechanically-patterned and not 
responding consistently to therapy (e.g. tendon 
unloading). 
Pattern of movement dysfunction (control or 
impairment of range) consistent with subjective 
complaint; warmth; crepitus; check for rotator cuff 
rupture. 
Partial or no response to simple analgesia. 
Secondary osteoarthritis Pattern of symptoms mechanically-patterned (i.e.; 
stimulus-response coupled: hurts and pain eases when 
resting), non-inflammatory joint degeneration. 
Age-dependent. 
Longer RA disease duration and/or chronic 
synovitis. 
Insidious onset. 
Responds to simple analgesia.  
Bony tenderness on palpation. 
Bony enlargement. 
Crepitus with movement. 
No palpable warmth (difficult if patient also has a 
flare). 
Loss of joint space, osteophytes, subchondral cysts 
on plain X-ray. 
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Abbreviations: MCP – metacarpophalangeal; IP – interphalangeal; MTP – metatarsophalangeal; PIP – proximal interphalangeal; DIP – distal 
interphalangeal   
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Table 2 Practice-relevant extra-articular manifestations and co-morbidities associated with rheumatoid arthritis, by body system, 
representing potential red flags.  
Body system Extra-articular manifestation What to look for Co-morbidities/complications What to look for 





Major cutaneous vasculitis a 
 
Single or multiple 
subcutaneous nodules, 
>5mm diameter. Usually 
painless and on extensor 
surfaces.  
Petechiae/purpura (red or 
purple skin lesions which do 
not blanch on pressure). Leg 
ulcers and peripheral 
gangrene (Figure 1). 
  






Interstitial lung disease a 
Dry cough, dyspnoea, 
wheezing, crackles on 
auscultation. 





Cardiovascular Pericarditis a 
 
Vasculitis a 
Chest pain, dyspnoea 
Palpitations. 
Signs of ischaemia or 
necrosis in affected 
organs/tissues. 
  
Neurological Mononeuritis multiplex a  
Peripheral neuropathy a 
 
Acute sensory and/or motor 
neuropathy, occurring as a 








Cervical myelopathy b 
 
 
compression, or diabetes. 
Neck pain, upper limb pain, 
sensory and motor changes 
in upper limbs, gait 
disturbances. 
 
Visual Sjögren’s syndrome 
 
 
Episcleritis, scleritis a, retinal 
vasculitis a 
 
Dry eyes and mouth. Skin, 
nose and vaginal dryness 
also present.  
‘Red eye’, eye pain, 
photophobia, decreased 
visual acuity, dry/itchy eye 
(Figure 2). 
  
Haematological Felty’s syndrome a, c Frequent bacterial infections, 
fever, weight loss, fatigue, 
splenomegaly. 
  





Minimal trauma fracture, 
height loss. 
Skin thinning, painful 
peripheral neuropathy. 
a Severe manifestations are classified according to the Malmö criteria (Turesson et al., 2000; Turesson & Jacobsson, 2004) 
b occurs as a consequence of subluxation of cervical spine joints due to instability of the cervical spine, especially the upper cervical spine (refer to 
Table 1) 
c defined as chronic polyarthritis, neutropenia and splenomegaly 
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CAPTIONS TO ILLUSTRATIONS 
Figure 1: Example of cutaneous vasculitis of the lower extremities 
 
Figure 2: Example of RA-associated episcleritis of the right eye, termed ‘red eye’ 
 
Figure 1: Example of cutaneous vasculitis of the lower extremities. The lesions do not 
blanch when pressure is applied. Reproduced through a licence agreement 
with DermNet NZ (http://dermnetnz.org/).  
Figure 2: Example of RA-associated episcleritis of the right eye, termed ‘red eye’. 
Reproduced through a licence agreement with Science Photo, UK 
(www.sciencephoto.com).  
